Differences in epitope recognition, isotype and titer of antisera to Plasmodium falciparum merozoite surface protein 4 raised by different modes of DNA or protein immunization

Vaccine

Volumn 19, Issue 7-8, 2000, Pages 816-824

  Wang, Lina ^a   Menting, John G T ^a   Black, Casilda G ^a   Stowers, Anthony ^b   Kaslow, David C ^b   Hoffman, Stephen L ^c   Coppel, Ross L ^a  

^a MONASH UNIVERSITY   (Australia)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

Antibody response; DNA vaccination; MSP4

Indexed keywords

DNA VACCINE; EPITOPE; MEROZOITE SURFACE PROTEIN 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MALARIA; MEROZOITE; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RECOGNITION; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; COS CELLS; EPITOPES; FEMALE; GENE EXPRESSION; GENES, PROTOZOAN; HUMANS; MALARIA VACCINES; MICE; MICE, INBRED C3H; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; TRANSFECTION; VACCINES, DNA; VACCINES, SUBUNIT;

EID: 0034703855     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00245-0     Document Type: Article

References (43)

1. Naked DNA points way to vaccines
2. DNA vaccines
3. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine
4. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein
5. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use
6. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites
7. Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines
8. DNA vaccines against malaria: immunogenicity and protection in a rodent model
9. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines
10. Multi-plasmid DNA vaccination avoids antigenic competition and enhances immunogenicity of a poorly immunogenic plasmid
11. Malaria DNA vaccines in Aotus monkeys
12. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids
13. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
14. A second merozoite surface protein (MSP-4) of Plasmodium falciparum that contains an epidermal growth factor-like domain
15. Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum
16. An improved plasmid DNA expression vector for direct injection into skeletal muscle
17. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi
18. Selection of different strains of Plasmodium falciparum for testing blood-stage vaccines in Aotus nancymai monkeys
19. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization
20. Humoral responses in mice following vaccination with DNA encoding glutathione S-transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression
21. Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP119) variants secreted from Saccharomyces cerevisiae
22. Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum
23. The complete nucleotide sequence of chromosome 3 of Plasmodium falciparum
24. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization
25. Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice
26. Induction of neonatal tolerance by plasmid DNA vaccination of mice
27. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains
28. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies
29. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth
30. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1
31. Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies
32. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains
33. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity
34. Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen
35. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization
36. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies
37. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery
38. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii
39. Heat-labile IgG2a antibodies affect cure of Trypanosoma musculi infection in C57BL/6 mice
40. Candidate antigens for an asexual blood stage vaccine against falciparum malaria
41. Identification of the Plasmodium chabaudi homologue of the merozoite surface protein 4 and 5 of Plasmodium falciparum
42. Characterisation of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii